David Trosin

NSF International

MoCRA and FDA Adoption of NSF/ANSI 455-3 National Cosmetic GMP

With MoCRA, Congress directed the FDA to seek existing consensus standards where practicable, to avoid overly burdensome requirements, and allow for flexibility within the regulations so manufacturers of all sizes and types can comply without undue economic hardship. These details'' importance and implications for industry are hard to overstate. There is a rare opportunity to enact a modern regulation that maximizes all possible benefits for stakeholders in the regulatory design.


This Schedule is not currently available